Skip to content

News

FDA Approves Olaparib for Ovarian Cancer

FDA Approves Olaparib for Ovarian Cancer

(December 19, 2014) The U.S. Food and Drug Administration (FDA) has approved AstraZeneca’s Olaparib (Lynparza) for advanced, BRCA-mutated ovarian cancer, the first approval of a drug in the PARP (poly … Continued

Partner Member Profile: Ovarian Cancer 101

Partner Member Profile: Ovarian Cancer 101

When Diane Riche’s mother was diagnosed with ovarian cancer in 2010, Diane turned to the internet for information. Through her research she came to the Alliance’s website, where she learned … Continued

Ovarian Cancer Research Fund Legends Gala

Ovarian Cancer Research Fund Legends Gala

OCRF’s 20th Anniversary Legends Gala, hosted by Harry Connick, Jr., was held on Wednesday,  November 5th at The Pierre Hotel in New York City. Honorees included the Janet Burros Memorial … Continued

Stay Informed

Get email updates about research news, action alerts, and ways to join the fight.

We care about your data. Read our privacy policy.